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Background: Accurate diagnosis of malaria is an essential prerequisite for proper treatment and drug resistance
monitoring. Microscopy is considered the gold standard for malaria diagnosis but has limitations. ELISA, PCR, and
Real Time PCR are also used to diagnose malaria in reference laboratories, although their application at the field
level is currently not feasible. Rapid diagnostic tests (RDTs) however, have been brought into field operation and
widely adopted in recent days. This study evaluates OnSite (Pf/Pan) antigen test, a new RDT introduced by CTK
Biotech Inc, USA for malaria diagnosis in a reference setting.
Methods: Blood samples were collected from febrile patients referred for malaria diagnosis by clinicians. Subjects
were included in this study from two different Upazila Health Complexes (UHCs) situated in two malaria endemic
districts of Bangladesh. Microscopy and nested PCR were considered the gold standard in this study. OnSite (Pf/Pan)
RDT was performed on preserved whole blood samples.
Results: In total, 372 febrile subjects were included in this study. Of these subjects, 229 (61.6%) tested positive for
Plasmodium infection detected by microscopy and nested PCR. OnSite (Pf/Pan) RDT was 94.2% sensitive (95% CI,
89.3-97.3) and 99.5% specific (95% CI, 97.4-00.0) for Plasmodium falciparum diagnosis and 97.3% sensitive (95% CI,
90.5-99.7) and 98.7% specific (95% CI, 96.6-99.6) for Plasmodium vivax diagnosis. Sensitivity varied with differential
parasite count for both P. falciparum and P. vivax. The highest sensitivity was observed in febrile patients with
parasitaemia that ranged from 501–1,000 parasites/μL regardless of the Plasmodium species.
Conclusion: The new OnSite (Pf/Pan) RDT is both sensitive and specific for symptomatic malaria diagnosis in
standard laboratory conditions.Background
While the number of malaria cases has declined in re-
cent times, 50% of the world’s population living in 106
countries is still at risk of malaria infection. In 2010, 216
million malaria cases were recorded worldwide. Africa
has the highest burden of malaria with 81% of the cases
and 91% of the deaths due to malaria globally [1].
Bangladesh is a hypo-endemic area for malaria
transmission with 13 endemic districts. In 2011,
52,598 malaria cases were reported in Bangladesh [2].
A large majority (95%) of malaria cases are caused by
Plasmodium falciparum infection in Bangladesh and
transmitted by a wide variety of malaria vectors [3,4].* Correspondence: shafiul@icddrb.org
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reproduction in any medium, provided the orAccurate diagnosis of malaria is the key factor not only
to prevent morbidity and mortality but also to restrict
the use of anti-malarial drugs to minimize the spread of
drug resistance [5]. Diagnostic improvement is necessary
in both economically underdeveloped malaria-endemic
countries where resource is the primary barrier, and in
non-endemic malaria regions, mostly the developed
countries, where the emphasis to develop expertise is
less of a concern due to lack of disease prevalence.
Although clinical diagnosis of malaria is paramount in
resource-limited areas, at times it raises doubt due to
the overlap of similar symptoms of other tropical dis-
eases and co-infection [6]. Furthermore, there are
marked variations in clinical diagnosis accuracy in differ-
ent age groups, and on the seasonality and level of en-
demicity of malaria in different settings [7,8].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of methylene blue and eosin stain [9]. Subsequently,
Giemsa-stained blood smear examination has become
the gold standard for malaria diagnosis worldwide. How-
ever, malaria microscopy has two main disadvantages.
Firstly, it is very difficult to implement, especially in
rural areas where very basic laboratory facilities are not
available. Secondly, test results vary from area to area
based on individual skills, quality of equipment and the
level of parasitaemia in a specimen. Even in the most
favourable conditions, sensitivity and specificity are close
to 80-90% [10].
Different approaches, including ELISA, PCR and Real
Time PCR have been utilized to improve malaria diagno-
sis. Although these methods improve sensitivity and spe-
cificity and are applicable in reference settings where
laboratory facilities are specialized available, these meth-
ods are difficult to implement at field level and can only
be used as a standard method to validate other methods
[11]. Immunochromatography-based rapid diagnostic
tests (RDTs) were introduced in the early 1990s. These
tests diagnose malaria using lateral flow of blood on a
nitrocellulose membrane causing an immunological reac-
tion with bound antibodies fixed on the distant location
of the membrane. Currently three types of target antigens
are detected in malaria RDTs by recombinant antibodies
[5]. Histidine-rich protein 2 (HRP2) is the target for
most RDTs that detect P. falciparum infection. Forms of
lactate dehydrogenases (pLDH) are used to identify both
P. falciparum and Plasmodium vivax infection and a vari-
ant can be used to detect all species (Pan-specific). The
third target antigen is aldolase, which is Pan-specific for
all malaria species. Combining any two of these three
antigen detection tests into malaria RDTs allow detection
of P. falciparum alone, P. vivax alone, or mixed infection
[12]. Research and training in tropical diseases has intro-
duced principles for the development and evaluation of
diagnostic tests for malaria and other infectious diseases
[13]. World Health Organization is also conducting evalu-
ation programmes to improve and control the quality of
RDTs [14]. Following the WHO strategy, the Government
of Bangladesh has incorporated RDTs into its National
Malaria Control Program (NMCP).
A number of malaria RDTs are available in local markets
and are being used for diagnosis throughout Bangladesh,
but their clinical proficiency needs to be evaluated. In this
study, a newly available RDT, OnSite (Pf /Pan) (CTK
Biotech Inc, USA), was evaluated compared to microscopy
adjusted with nested PCR as the gold standard.
Methods
Study area and population
Whole blood samples were obtained from two different
sub-districts of the south-eastern part of Bangladesh:Matiranga Upazila in Khagrachhari district and Ramu
Upaliza in Cox’s Bazar district. Subjects were enrolled
into the study at the Upazila Health Complexes (UHCs).
Febrile patients identified by clinical symptoms and
referred to laboratory investigations from May 2009 to
December 2010 were included in this study. Samples
were excluded from the study in the case of mixed
infection or differential diagnosis by the standard
methods (microscopy and nested PCR).
Sample collection
Approximately 5 mL of blood was taken through
venipuncture from adult subjects by an expert medical
technologist. In the case of children or minor subjects,
approximately 3 mL of blood was taken. Thick and thin
smear slides were prepared in duplicate using two drops
of blood for each sample. The remaining blood was pre-
served at −20°C in EDTA tube and transported to the
icddr,b Dhaka laboratory in cool boxes, maintaining the
temperature below 4°C using ice bags.
Microscopy
Microscopy was conducted at the field site by experi-
enced microscopists following the standard procedure
[11] in the corresponding UHC. The microscopy results
were cross checked at the icddr,b Dhaka laboratory by a
second, independent, experienced microscopist.
Rapid diagnostic tests (RDT)
Onsite (Pf/Pan) RDT device, produced by CTK Biotech
Inc, USA, was evaluated in this study. This device has
the ability to detect Pan-specific lactate dehydrogenase
(pLDH) and P. falciparum specific HRP-2.
All RDTs were performed on six months to two years
preserved samples at the Parasitology Laboratory, icddr,
b Dhaka. If both LDH and HRP line or only HRP line is
found then the experimental sample is considered as
P. falciparum positive. Conversely, only LDH positive
samples were diagnosed as non- falciparum, exclusively
P. vivax in this study. These RDTs were stored between
20-25°C at the icddr,b Dhaka laboratory.
DNA extraction
DNA extraction was done using QiaAmp blood mini kit
from Qiagen, Germany according to the manufacturer’s
instructions from preserved whole blood.
Nested PCR
A modified version of the nested PCR approach
described by Snounou et al. [15] was used to confirm
the results obtained by microscopy. Taq polymerase,
PCR buffer, dNTPs and magnesiun chloride were
obtained from New England BioLabs Inc, USA. All reac-
tions were carried out in Biorad C1000 thermal cycler
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by Biorad gel documentation system in a 1.5% agarose
gel after ethidium bromide staining.
Data analysis
All data analysis was conducted in Stata version 11.0
(StataCorp, College Station Texas, USA). Sensitivity, spe-
cificity, predictive values and accuracy were calculated
with their corresponding 95% confidence intervals (95%
CI) by McNemar test and exact McNemar test using the
‘diagt’ command.
Ethical approval
The study was approved by the Research Review Com-
mittee and Ethical Review Committee of icddr,b.
Informed consent was obtained from all adult subjects,
and assent was obtained from the legal guardians in the
case of minor subjects before the collection of blood
sample. Complete anonymity was maintained in all
stages of the study. Good clinical and laboratory prac-
tices were followed in all the procedures.
Results
Enrolment
After adjusting microscopy with nested PCR, blood sam-
ples from 372 febrile patients were included in this
evaluation. Of these subjects, 52.8% were male and
47.2% were female and the age of the subjects ranged
from 1.5 years to 82 years with a median of 19.4 years.
Microscopy confirmed by nested PCR
Malaria cases were confirmed by both microscopy and
nested PCR. There were 229 positive malaria cases
(61.6%). Among these cases, 68.1% (156/229) were
infected with P. falciparum and 31.9% (73/229) by
P. vivax (Table 1). The parasitaemia of P. falciparum
ranged from 16 to 261,480 parasites/μL (IQR: 7,680-
48,730) with median value of 19,960 parasites/μL. Only
3.8% (6/156) of samples had less than 100 parasites/μL
while 89.1% (139/156) of samples contained 1,000
parasites/μL or more. For P. vivax infection, the minimum
count was identical to P. falciparum (16 parasites/μL)
whereas the maximum parasite density observed was
25,120 parasites/μL (IQR: 680–7,220) with a median para-
sitaemia of 1,950 parasites/μL. The majority of P. vivax
samples had a parasitaemia greater than 1,000 parasites/μL
(63%, 46/73).Table 1 Summary of the results from different malaria diagno
Test Negative
Microscopy and nested PCR 143 (38.4)
OnSite (Pf/Pan) 149 (40.1)OnSite (Pf/Pan) rapid diagnostic test
Onsite (Pf/Pan) RDT was 94.2% sensitive (95% CI,
89.3-97.3) and 99.5% specific (95% CI, 97.4-100.0) for
P. falciparum diagnosis. The sensitivity and specificity
for P. vivax diagnosis were 97.3% (95% CI, 90.5-99.7)
and 98.7% (95% CI, 96.6-99.6), respectively. Sensitivity,
specificity, positive predictive value (PPV) and negative
predictive values (NPV) are shown in Table 2. In terms
of parasitaemia, the lowest sensitivity was observed
in samples with less than 100 parasites/μL for both
P. falciparum (50%) and P. vivax (80%). The maximum
sensitivity (100%) was observed in samples where the
parasitaemia was between 501–1,000 parasites/μL for
both species. It was evident that sensitivity increased
with increasing parasitaemia (Table 3).
Discussion
OnSite (Pf/Pan), a newly available RDT for malaria diag-
nosis, performed well in this study. OnSite (Pf/Pan)
RDT was 96.7% sensitive and 98.6% specific with
varying performance for P. falciparum and P. vivax
detection. OnSite (Pf/Pan) RDT has inherent capability
to detect all types of non-falciparum malaria but only
P. vivax was considered in this study due to the absence
of Plasmodium malariae and Plasmodium ovale sam-
ples in the study areas. In the case of P. falciparum, the
sensitivity ranged from 50% to 100% depending on the
parasitaemia.
The World Health Organization recommends at least
95% sensitivity of RDTs for low parasite counts [5]. As
like many other malaria RDTs, OnSite (Pf/Pan) failed
to achieve this level of sensitivity. However, only six
P. falciparum and five P. vivax samples had parasite
loads below 100 parasites/μL in this study. Therefore,
the low sensitivity observed in low parasitaemia samples
may have been driven by the lack of sample size and it
cannot be concluded that OnSite (Pf/Pan) does not per-
form well in low parasitaemia samples.
In the case of P. vivax, the sensitivity consistently
increased as the parasite load increased. This supports
the idea of the intra-species conserved nature of pLDH
[16]. For P. falciparum, the sensitivity did not always
increase as the parasite load increased (Table 3). This
occurred because one sample with parasitaemia greater
than 1,000 parasites/μL and three samples with parasit-
aemia greater than 5,000 parasites/μL tested negative by
RDT. It is possible that this was caused by deterioration
of the target antigen (HRP-2) as the tests werestic tests
Pf Pv Total positive
156 (41.9) 73 (19.6) 229 (61.6)
148 (39.8) 75 (20.2) 223 (59.9)
Table 2 Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of OnSite (Pf/Pan)
in comparison with microscopy adjusted by nested PCR as gold standard
Method Test type Sensitivity (95% CI) Specificity(95% CI) PPV(95% CI) NPV(95% CI) Agreement
OnSite (Pf/Pan) Pf 94.2 (89.3 -97.3) 99.5 (97.4 - 100.0) 99.3 (96.3 - 100.0) 96.0 (92.5 - 98.1) 0.973
OnSite (Pf/Pan) Pv 97.3 (90.5 - 99.7) 98.7 (96.6 -99.6) 94.7 (86.9 - 98.5) 99.3 (97.6 -99.9) 0.984
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for this observation is intra-species variation in the gene
encoding the HRP gene [17] or deletion of the gene [18]
among different P. falciparum isolates; however this was
not assessed, as it was beyond the scope of this study.
One negative sample was falsely tested as P. falciparum
positive followed by another one as P. vivax by OnSite
(Pf/Pan) RDT which might be due to cross reactivity of
other infections, such as rheumatoid factor, heterophe-
line antibodies [19]. Histidine-rich protein can persist in
the blood for more than one month even after a patient
is cured of malaria [20], which could also be the cause
for false positivity in this observation. Conversely, three
confirmed P. falciparum samples tested positive in Pan
line but HRP2 line did not appear. This might be due to
inherent limitation of the device, intra-species variation
in the gene encoding the HRP gene or deletion of HRP
gene.
OnSite (Pf/Pan) RDT was also incorporated into the
WHO RDT evaluation programme in Round 3 and eval-
uated with good score[14]. This RDT tested to have
83.8% and 85.7% detection rate/score for P. falciparum
and P. vivax, respectively, when parasitaemia were 200
parasites/μL. Furthermore, it had 100% detection rate/
score for species in the cases of parasitaemia at 2,000
parasites/μL or more in WHO Panel. This study also
reveals an almost similar level of sensitivity especially for
higher parasite load, denoting the accuracy of this RDT
in identifying symptomatic malaria cases.
OnSite (Pf/Pan) performed better than some similar
RDTs developed and widely adopted for malaria diagnosis.
Parascreen Pf/Pan RDT was evaluated in different studies
[20-26] where it showed maximum sensitivity of 94% and
specificity of 72% for P. falciparum detection. For Pan de-
tection, it showed a maximum sensitivity of 82.5% and
specificity of 78.2% for symptomatic patients [26].
OptiMAL (Pf/Pan) is another similar RDT that has been
implemented in both the field and the laboratory and hasTable 3 Sensitivity of OnSite (Pf/Pan) RDT by parasitaemia





5,000+ 123 21been evaluated several times [27-30]. Sensitivity ranged
from 91.2%-95.4% for P. falciparum and 60.7%-100% for
P. vivax malaria while specificity was close to 95% or
above [27,28].
CareStart™ (Pf/Pan) was also evaluated in several ex-
perimental conditions [20,27,30-35]. Its overall sensitiv-
ity varies from a minimum of 88.24% [32] to maximum
95.6% [30], while the specificities were close to 95%.
The highest sensitivity for P. falciparum diagnosis was
observed at 99.4% in Sierra Leone [33] while the lowest
reported was 85.6% in Ethiopia [20] with high specificity
in all relevant studies. For P. vivax diagnosis, the high-
est sensitivity was 92.3% in a study in Madagascar [30]
while lowest was 85% [20] in the same study in Ethiopia
where P. falciparum detection sensitivity was lowest
[29]. Specificities of P .vivax detection tests were always
very good, above 95% in recent studies.
Compared to the performance of various other RDTs
with similar characteristics, OnSite (Pf/Pan) can be con-
sidered an effective diagnostic tool for detecting both
P. falciparum and P. vivax malaria. This test has high
positive predictive value and negative predictive value
which indicates that it is capable of detecting true malaria
cases as well as excluding non-malaria cases with overlap-
ping symptoms to reduce treatment burden, which hap-
pens to be the major concern since artemisinin-based
combination therapy is the last oral option presently used
in these areas against P. falciparum.
This study used frozen blood samples and well pre-
served devices for evaluating OnSite (Pf/Pan) RDT,
which may not be controlled in field settings. Thus, a
slight variant result may be possible in the case of fresh
blood samples in ambient field settings.
Conclusion
OnSite (Pf/Pan) RDT, newly manufactured by CTK
Biotech Inc, USA, performed satisfactorily in standard
experimental conditions. It can be utilized for diagnosisositive sample (n) Pf sensitivity (95% CI) Pv sensitivity (95% CI)
50 (13.9-86.1) 80 (29.9-98.9)
60 (17.1-92.1) 90 (54.1-99.5)
100 (51.7-100) 100 (69.9-100)
93.8 (67.7-99.7) 100 (83.4-100)
97.6 (92.5-99.4) 100 (80.8-100)
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arum malaria infection from vivax malaria in endemic
areas and during outbreaks. However, a field evaluation
is required to assess its applicability for routine diagnosis
in resource-limited settings where the feasibility of mi-
croscopy is limited. Careful monitoring should be main-
tained at the level of manufacturing and post-marketing
surveillance to assure quality in different lots.
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